Variation in genetic risk explains which people develop type 1 diabetes in later life

September 12, 2017
Variation in genetic risk explains which people develop type 1 diabetes in later life
Study suggests genetic predisposition for late onset type 1 diabetes. Credit: University of Exeter

Having certain genetic variants could explain why people can develop type 1 diabetes at markedly different ages, including later in life, says new University of Exeter research being presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal (11-15 Sept). The study is the first to suggest there is a specific genetic predisposition for late onset type 1 diabetes.

Type 1 diabetes (T1D) is caused by an autoimmune attack in the body killing off the in the pancreas, eventually leaving most people with a life-long dependency on insulin. It is typically affects children and but can affect patients after the age of 30 years (referred to as late onset T1D). The Prime Minister Theresa May is an example of someone with late onset T1D, diagnosed early in 2013 at the age of 56. Often, people with late onset T1D have their condition confused with type 2 diabetes, which is much more common in older adults.

Certain groups of genes associated with regulation of the immune system in humans are known to be linked to the risk of developing T1D. The major genetic determinants are the DR3 and DR4 alleles (or variants) of a group of genes called the HLA complex. The strongest risk occurs when these risk alleles occur in pairs which can either be homozygous (DR3/DR3 or DR4/DR4), or compound heterozygous (DR3/DR4) genotypes.

This study was conducted by Dr Nick Thomas, along with Professor Andrew Hattersley and other colleagues at the University of Exeter Medical School, and aimed to investigate whether the increased risk of T1D that is observed in children and young adults with the DR3 and DR4 genotypes persists into adulthood.

The team analysed the development of T1D diabetes in a population of 120,000 individuals from the UK Biobank from birth to age 60 in subjects selected from the highest risk HLA groupsThey found that although the highest risk genotypes made up just 6.4% of the UK population, they contributed 61% of all cases of T1D. Within these high-risk groups there were marked differences in both the likelihood of developing T1D and the average age of diagnosis.

In the high-risk HLA groups DR3/DR3, DR3/DR4 and DR4/DR4 there were marked differences in likelihood of developing T1D during a person's lifetime: 1.2%, 4.2%, and 3.5% respectively.The authors found that for the DR3/DR3, DR3/DR4, and DR4/DR4 genotypes, the mean age of diagnosis was 17, 28, and 38 years old respectively, with 71% of T1D cases associated with the DR4/DR4 being diagnosed in individuals over the age of 30. For DR3/DR3/ just 26% were diagnosed over 30, while for DR3/DR4 the figure was 40%.

The authors conclude that: "Whilst all three major genotypes greatly increase risk of T1D throughout life, population analysis has shown for the first time that DR4/DR4 specifically predisposes to T1D over 30 years of age and carriers of this genotype have the highest risk for development of late-onset T1D".

They add: "This is clear evidence that type 1 diabetes after 30 years is not just a delayed version of type 1 before 30. Further work is needed to understand these differences."

Explore further: Genetic findings in 'type 1.5' diabetes may shed light on better diagnosis, treatment

Related Stories

Genetic findings in 'type 1.5' diabetes may shed light on better diagnosis, treatment

May 4, 2017
Researchers investigating a form of adult-onset diabetes that shares features with the two better-known types of diabetes have discovered genetic influences that may offer clues to more accurate diagnosis and treatment.

Researchers find biomarker that could help predict the onset of type 1 diabetes

March 28, 2017
A significant finding has been made by the 3U Diabetes Consortium, of Dublin City University, Maynooth University and the Royal College of Surgeons in Ireland (RCSI), which has the potential to contribute to the identification ...

New immune cell subset associated with progression to type 1 diabetes

October 11, 2016
A study conducted at the University of Eastern Finland revealed that a recently described T cell subset may have a central role in the development of type 1 diabetes. These so called follicular T helper cells were found to ...

Childhood obesity linked to quadrupled risk of developing type 2 diabetes

April 25, 2017
Children with obesity face four times the risk of developing type 2 diabetes compared to children with a body mass index (BMI) in the normal range, according to a study published today in the Journal of the Endocrine Society.

Chronic hepatitis B prevalence higher in those with T2DM

December 23, 2016
(HealthDay)—Patients with type 2 diabetes have higher prevalence of chronic hepatitis B virus infection (CHB), according to a study published online Dec. 8 in the Journal of Diabetes Investigation.

Serum trypsinogen levels down in type 1 diabetes

January 26, 2017
(HealthDay)—Patients with type 1 diabetes have significantly lower serum trypsinogen levels than those without type 1 diabetes, according to a study published online Jan. 23 in Diabetes Care.

Recommended for you

Controlling diabetes with your phone might be possible someday

November 21, 2017
Think about this. You have diabetes, are trying to control your insulin levels and instead of taking a pill or giving yourself an injection, you click an app on your phone that tells your pancreas to bring blood sugar levels ...

Insulin pill may delay type 1 diabetes in some

November 21, 2017
(HealthDay)—It's often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes.

Simple test predicts diabetes remission following weight loss surgery

November 21, 2017
A new simple test that helps predicts which people with type 2 diabetes will benefit most from weight loss surgery has been developed by a UCL-led team.

Pre-diabetes discovery marks step towards precision medicine

November 20, 2017
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection ...

Scientists reverse diabetes in a mouse model using modified blood stem cells

November 15, 2017
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-treated to produce more of a protein called PD-L1, which is deficient in mice (and people) ...

Pregnancy-related conditions taken together leave moms—and dads—at risk

November 14, 2017
Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.